Quit with GLP
The Quit with GLP Study is a multi-site clinical trial for adults who smoke cigarettes and are interested in quitting smoking.This study is being conducted in four cities: Los Angeles, CA, Chicago, IL, Aurora/Denver, CO, and New Haven, CT. Participants must live in or near one of these cities to attend weekly visits.This study may be a good fit for you if:• You are between the ages of 21-65
• You live in the Los Angeles, Chicago, Aurora/Denver, or New Haven areas
• You currently smoke cigarettes and are interested in quitting
• Your body mass index (BMI) is 25 kg/m2 or greater - to calculate your BMI click here.
• You are willing to take the study medication (tirzepatide) while attending regular visits for 7-8 months.Participants will be compensated for study visits.Participants will also receive free study medication and nicotine replacement therapy.
Select your city:
Study Information:
Multi-Site Trial of Tirzepatide for Smoking Cessation
Sponsor: University of Southern California (IRB # HS-25-00642)
Funding: National Institute on Drug Abuse (U01DA064384-01)
ClinicalTrials.gov ID: NCT07602699
Central Contact Email: smokingstudy (at) usc.edu
University of Southern California
Location: Los Angeles, California, United States, 90033
Recruiting - Keck School of Medicine, University of Southern CaliforniaContact: smokingstudy (at) usc.eduClick the link below to see if you are eligible.
Study Information:
Multi-Site Trial of Tirzepatide for Smoking Cessation
Sponsor: University of Southern California (IRB # HS-25-00642)
Funding: National Institute on Drug Abuse (U01DA064384-01)
ClinicalTrials.gov ID: NCT07602699
Central Contact Email: smokingstudy (at) usc.edu
University of Colorado Anschutz
Location: Aurora/Denver, Colorado, United States, 80045
Recruiting - University of Colorado Anschutz Medical CampusContact: smokingstudy (at) cuanschutz.edu.Click the link below to see if you are eligible.
Study Information:
Multi-Site Trial of Tirzepatide for Smoking Cessation
Sponsor: University of Southern California (IRB # HS-25-00642)
Funding: National Institute on Drug Abuse (U01DA064384-01)
ClinicalTrials.gov ID: NCT07602699
Central Contact Email: smokingstudy (at) usc.edu
Yale University
Location: New Haven, Connecticut, United States, 06510
Recruiting - Yale University School of MedicineContact: Sabrina.coppola (at) yale.edu
203-737-2827Click the link below to see if you are eligible.
Study Information:
Multi-Site Trial of Tirzepatide for Smoking Cessation
Sponsor: University of Southern California (IRB # HS-25-00642)
Funding: National Institute on Drug Abuse (U01DA064384-01)
ClinicalTrials.gov ID: NCT07602699
Central Contact Email: smokingstudy (at) usc.edu
University of Chicago
Location Chicago, Illinois, United States, 60637
Recruiting - University of Chicago Pritzker School of MedicineContact: smokingstudy (at) lists.uchicago.eduClick the link below to see if you are eligible.
Study Information:
Multi-Site Trial of Tirzepatide for Smoking Cessation
Sponsor: University of Southern California (IRB # HS-25-00642)
Funding: National Institute on Drug Abuse (U01DA064384-01)
ClinicalTrials.gov ID: NCT07602699
Central Contact Email: smokingstudy (at) usc.edu